atomoxetine hydrochloride has been researched along with yohimbine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Corbit, LH; Janak, PH | 1 |
García-Bueno, B; Hinojosa, AE; Leza, JC; Madrigal, JL | 1 |
Biaggioni, I; Black, BK; Choi, L; Diedrich, A; Gamboa, A; Okamoto, LE; Raj, SR; Robertson, D; Shibao, C | 1 |
Milic, M; Ziegler, MG | 1 |
Floresco, SB; Hosking, JG; Winstanley, CA | 1 |
1 trial(s) available for atomoxetine hydrochloride and yohimbine
Article | Year |
---|---|
Synergistic effect of norepinephrine transporter blockade and α-2 antagonism on blood pressure in autonomic failure.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Aged; Atomoxetine Hydrochloride; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Norepinephrine Plasma Membrane Transport Proteins; Postural Balance; Propylamines; Prospective Studies; Shy-Drager Syndrome; Single-Blind Method; Treatment Outcome; Yohimbine | 2012 |
5 other study(ies) available for atomoxetine hydrochloride and yohimbine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Deepened extinction following compound stimulus presentation: noradrenergic modulation.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Brain; Extinction, Psychological; Male; Norepinephrine; Propranolol; Propylamines; Rats; Rats, Sprague-Dawley; Yohimbine | 2011 |
Regulation of CCL2/MCP-1 production in astrocytes by desipramine and atomoxetine: involvement of α2 adrenergic receptors.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic Uptake Inhibitors; Animals; Astrocytes; Atomoxetine Hydrochloride; Cells, Cultured; Chemokine CCL2; Clonidine; Cyclic AMP; Desipramine; Isoproterenol; Norepinephrine; Propylamines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Yohimbine | 2011 |
New therapies for postural hypotension.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Blood Pressure; Female; Humans; Male; Norepinephrine Plasma Membrane Transport Proteins; Propylamines; Shy-Drager Syndrome; Yohimbine | 2012 |
Dopamine antagonism decreases willingness to expend physical, but not cognitive, effort: a comparison of two rodent cost/benefit decision-making tasks.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention; Cognition; Cost-Benefit Analysis; Decision Making; Dopamine; Dopamine Antagonists; Male; Models, Animal; Motivation; Neuropsychological Tests; Norepinephrine; Physical Exertion; Rats; Rats, Long-Evans; Reward; Salicylamides; Yohimbine | 2015 |